| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410015A1 Methods of transducing neural cells using lentivirus vectors |
| 12/06/2001 | CA2409927A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| 12/06/2001 | CA2409617A1 2,7-naphthyridine derivatives |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | CA2408793A1 Use of a celecoxib composition for fast pain relief |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160320A1 Use of hTAFII80 and isoforms thereof for inducing apoptosis |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1160255A1 Monovalent antibody fragments |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1159457A1 T cell receptor vbeta beta-jbeta) sequence and methods for its detection |
| 12/05/2001 | EP1159455A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 12/05/2001 | EP1159404A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159294A1 Carbohydrate epitope mimic peptides and uses thereof |
| 12/05/2001 | EP1159292A2 Compounds having growth hormone releasing activity |
| 12/05/2001 | EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159275A2 Imidazole compounds as histamine h3 ligands |
| 12/05/2001 | EP1159274A2 Method for the preparation of citalopram |
| 12/05/2001 | EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s |
| 12/05/2001 | EP1159263A1 Novel sulfonamide compounds and uses thereof |
| 12/05/2001 | EP1159258A1 Amide compounds for the potentiation of cholinergic activity |
| 12/05/2001 | EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 12/05/2001 | EP1159012A1 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | EP1158992A1 Use of xenon for treating neurointoxications |
| 12/05/2001 | EP1158984A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158950A1 Anticonvulsant derivatives useful in treating essential tremor |
| 12/05/2001 | EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 12/05/2001 | EP1067904B1 Solid, quick dissolving cetirizine formulations |
| 12/05/2001 | EP0994872B9 4-phenylpiperidine compounds |
| 12/05/2001 | EP0970195A4 Fatty-acid amide hydrolase |
| 12/05/2001 | EP0863760B1 Use of antimineralocorticoid compounds against drug withdrawal syndrome |
| 12/05/2001 | EP0851856B1 Indole derivatives as melatoninergic analogues |
| 12/05/2001 | EP0846114B1 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 12/05/2001 | EP0845988B1 Novel fused isoquinolines as dopamine receptor ligands |
| 12/05/2001 | EP0845003B1 Novel opioid peptides |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | EP0779886B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 12/05/2001 | EP0710112B1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 12/05/2001 | CN1325452A Method for the preparation of quercetin and isoquercetin derivatives |
| 12/05/2001 | CN1325450A Adenovirus-mediated gene therapy |
| 12/05/2001 | CN1325408A Compounds with growth hormone releasing propenties |
| 12/05/2001 | CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 12/05/2001 | CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands |
| 12/05/2001 | CN1325396A Aryl-{4-fluoro-4-[(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 12/05/2001 | CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325385A Gastrin and cholecystokinin receptor ligands |
| 12/05/2001 | CN1325377A New esters derived from substituted phenyl-cyclohexyl compounds |
| 12/05/2001 | CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases |
| 12/05/2001 | CN1325307A Remedies for spinal canal stenosis |
| 12/05/2001 | CN1325304A 5HT1 receptor agonists and metoclopramide for treatment of migraine |
| 12/05/2001 | CN1325301A Controlled delivery of active agents |
| 12/05/2001 | CN1324821A New human neurotrophic fator and its encoding sequence, prepn. and use |
| 12/05/2001 | CN1324636A Patent Chinese medicine for preventing lung cancer and relieving tabacism and preparation method thereof |
| 12/05/2001 | CN1324634A Paraplegia treating pill |
| 12/05/2001 | CN1324621A Production process of obtaining non-toxic effective buthotoxin |
| 12/05/2001 | CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor |
| 12/05/2001 | CN1075812C Prodrugs of morpholine tachykinin receptor antagonists |
| 12/05/2001 | CN1075809C Novel vitamin D analogues |
| 12/05/2001 | CN1075727C Capsule for treating nervous lesion and production method thereof |
| 12/04/2001 | US6326507 Therapeutic compounds and methods of use |
| 12/04/2001 | US6326398 Oxamic acids and derivatives as thyroid receptor ligands |
| 12/04/2001 | US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| 12/04/2001 | US6326387 Methods and compositions for stimulating neurite growth |
| 12/04/2001 | US6326385 Administering poltassium channel modulator |
| 12/04/2001 | US6326383 Emesis therapy |
| 12/04/2001 | US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 12/04/2001 | US6326377 Psychological disorders therapy |
| 12/04/2001 | US6326375 Containing an urea group |
| 12/04/2001 | US6326374 Analgesics; containing gamma aminobutyric acid |
| 12/04/2001 | US6326371 Pyrudyl and pyrimidylpiperazine derivatives |
| 12/04/2001 | US6326370 Use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 12/04/2001 | US6326368 Psychological disorders |
| 12/04/2001 | US6326359 Adenosine A2A receptor agonists as antiinflammatory agents |
| 12/04/2001 | US6326352 Compounds and methods for modulating cell adhesion |
| 12/04/2001 | US6326156 Screening nervous system and psychological disorders; incubate receptor with modlator, detect inductive activity, detect reduction in defect nervous system and psychological activity |
| 12/04/2001 | US6326027 Solid, oral dosage form, comprising tramadol or its salt in matrix providing at least twelve hour effectiveness |
| 12/04/2001 | US6326022 Stretchable, elastic mushroom-shaped permeable elastomer polymer matrix containing active ingredient; inserted and gripped between teeth; drug, nicotine and odorant delivery |
| 12/04/2001 | CA2229814C Peripherally active anti-hyperalgesic opiates |
| 12/04/2001 | CA2218452C Novel ligands of the neuropeptide receptor hfgan72 |
| 12/04/2001 | CA2208836C Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 12/04/2001 | CA2171882C Inhibitors of .beta.-amyloid protein production |
| 12/04/2001 | CA2098301C Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 12/04/2001 | CA2042327C Pyrrolo¬2,3-b|indole-ketones and analogs, a process for their preparation and their use as medicaments |
| 12/04/2001 | CA1341324C Esterase enzymes used in the process for the preparation of 2-arylpropionic acids |